These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37641883)

  • 1. A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine.
    Wang R; Wang M
    J Dermatol; 2023 Dec; 50(12):1625-1628. PubMed ID: 37641883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis.
    Wang G; Hu X; Han S; Zhou M
    J Dermatolog Treat; 2024 Dec; 35(1):2366535. PubMed ID: 38945532
    [No Abstract]   [Full Text] [Related]  

  • 3. Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction.
    Wang R; Wang A; Wang M
    J Dermatol; 2023 Jul; 50(7):956-959. PubMed ID: 36880309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies.
    Isogai R; Kawada A; Aragane Y; Amagai M; Tezuka T
    J Dermatol; 2004 May; 31(5):407-10. PubMed ID: 15187309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib.
    Xiao Y; Xiang H; Li W
    Dermatol Ther; 2022 Oct; 35(10):e15754. PubMed ID: 35920701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid induced by ustekinumab: a case report.
    Marin M; Alzueta N; Castresana M; Gascón A; Pío M
    Eur J Hosp Pharm; 2021 Jan; 28(1):47-49. PubMed ID: 33355283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus vulgaris with psoriasis vulgaris successfully treated with methotrexate and low-dose methylprednisolone.
    Zheng J; Liu N; Wang Y; Chen F; Ding Y
    Dermatol Ther; 2020 Jan; 33(1):e13165. PubMed ID: 31705774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bullous pemphigoid during secukinumab treatment for psoriasis.
    Ho PH; Tsai TF
    J Dermatol; 2017 Sep; 44(9):e220-e221. PubMed ID: 28543960
    [No Abstract]   [Full Text] [Related]  

  • 10. Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.
    Burlando M; Capurro N; Herzum A; Cozzani E; Parodi A
    Dermatol Ther; 2022 Jan; 35(1):e15207. PubMed ID: 34791777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of pemphigus and bullous pemphigoid.
    Matsubara K; Kanauchi H; Tanaka T; Imamura S
    J Dermatol; 1995 Jan; 22(1):68-71. PubMed ID: 7897029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report.
    Yun JS; Scardamaglia L; Tan CG; McCormack CJ
    Australas J Dermatol; 2022 May; 63(2):e155-e158. PubMed ID: 35138643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
    Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
    J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid associated with psoriasis: a good response to methotrexate.
    Vargas P; Giacaman P; Fernández J; Morales C
    An Bras Dermatol; 2019; 94(2):224-226. PubMed ID: 31090831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of pemphigoid vegetans with autoantibodies against the BP180 C-terminal domain and BP230 antigen.
    Doi C; Shiraishi K; Koga H; Ishii N; Sayama K
    J Dermatol; 2021 Aug; 48(8):1286-1290. PubMed ID: 34003521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.